• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

134.58 +0.92 (+0.69%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,165,843
Open 132.23
Bid (Size) 132.81 (11)
Ask (Size) 140.00 (1)
Prev. Close 133.66
Today's Range 131.81 - 136.28
52wk Range 92.14 - 183.00
Shares Outstanding 136,546,580
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Natera Highlights Latest Prospera™ Data at WTC 2025; 16 Abstracts Including Five Oral Presentations
August 01, 2025
From Natera, Inc.
Via Business Wire
Natera to Report Its Second Quarter Results on August 7, 2025
July 31, 2025
From Natera, Inc.
Via Business Wire

Performance

YTD
-16.2%
-16.2%
1 Month
-16.7%
-16.7%
3 Month
-14.2%
-14.2%
6 Month
-23.9%
-23.9%
1 Year
+30.7%
+30.7%

More News

Read More
Natera Announces Launch of ABCSG 61 (“TEODOR”), a Randomized Controlled Trial of Signatera™ in Early-Stage Breast Cancer
July 29, 2025
From Natera, Inc.
Via Business Wire
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
July 28, 2025
Via Benzinga
PEDAL Study Successful, Shows Monitoring with Prospera™ Kidney Provides Accurate Prognosis of Long-Term Clinical Outcomes Following Rejection; Now Published in AJT
July 24, 2025
From Natera, Inc.
Via Business Wire
Schlumberger, Stellantis And ASML Holding Are Among Top 10 Large Cap Losers Last Week (July 14-July 18): Are The Others In Your Portfolio?
July 20, 2025
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
July 15, 2025
Via Benzinga
1 Unprofitable Stock for Long-Term Investors and 2 to Approach with Caution
July 08, 2025
Via StockStory
Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer
July 07, 2025
From Natera, Inc.
Via Business Wire
1 Growth Stock with Exciting Potential and 2 to Be Wary Of
July 03, 2025
Via StockStory
Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD
July 01, 2025
From Natera, Inc.
Via Business Wire
Q1 Immuno-Oncology Earnings Review: First Prize Goes to Natera (NASDAQ:NTRA)
June 29, 2025
Via StockStory
Topics Artificial Intelligence
Here's How Much $100 Invested In Natera 10 Years Ago Would Be Worth Today
June 26, 2025
Via Benzinga
1 Volatile Stock to Own for Decades and 2 to Brush Off
June 26, 2025
Via StockStory
Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks
June 22, 2025
Via StockStory
Topics Artificial Intelligence
3 Reasons We Love Natera (NTRA)
June 20, 2025
Via StockStory
Topics Government Stocks
Here's How Much You Would Have Made Owning Natera Stock In The Last 10 Years
June 13, 2025
Via Benzinga
A Look Back at Immuno-Oncology Stocks’ Q1 Earnings: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Pack
June 11, 2025
Via StockStory
Topics Artificial Intelligence
NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase
June 10, 2025
Via StockStory
9 Health Care Stocks Whale Activity In Today's Session
June 04, 2025
Via Benzinga
Natera Announces Medicare Coverage for Signatera™ Genome
June 04, 2025
From Natera, Inc.
Via Business Wire
SignateraTM Genome Clinical Performance Highlighted at ASCO 2025
June 02, 2025
From Natera, Inc.
Via Business Wire
2 Cash-Heavy Stocks for Long-Term Investors and 1 to Be Wary Of
June 02, 2025
Via StockStory
3 Mid-Cap Stocks Worth Your Attention
May 27, 2025
Via StockStory
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
May 26, 2025
Via Benzinga

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?
Yes, Natera, Inc. - Common Stock is publicly traded.
What exchange does Natera, Inc. - Common Stock trade on?
Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Natera, Inc. - Common Stock?
The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
What is the current price of Natera, Inc. - Common Stock?
The current price of Natera, Inc. - Common Stock is 134.58
When was Natera, Inc. - Common Stock last traded?
The last trade of Natera, Inc. - Common Stock was at 08/01/25 04:00 PM ET
What is the market capitalization of Natera, Inc. - Common Stock?
The market capitalization of Natera, Inc. - Common Stock is 18.38B
How many shares of Natera, Inc. - Common Stock are outstanding?
Natera, Inc. - Common Stock has 18B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap